Research in action
FDA approves treatment for rare condition
Published Sept 25, 2025 VideoFirst-of-its-kind therapy developed by Johns Hopkins researchers cleared for treatment of Barth syndrome, a condition that causes muscle weakness, an enlarged heart, and shortened life expectancy